Evidence map›Paper›PMID 36625587›Full record

ArticlemSphere2023

SARS-CoV-2 Transmission from Virus-Infected Dead Hamsters.

Kiyoko Iwatsuki-Horimoto, Hiroshi Ueki, Mutsumi Ito, Sayaka Nagasawa, Yuichiro Hirata, Kenichiro Hashizume, Kazuho Ushiwata, Hirotaro Iwase, Yohsuke Makino, Tetsuo Ushiku and 4 more

Open access · goldAbstract read
In one paragraph

Article in mSphere, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Kiyoko Iwatsuki-HorimotoDivision of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.ORCID 0000-0002-8266-020X
Hiroshi UekiDivision of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Mutsumi ItoDivision of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Sayaka NagasawaDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yuichiro HirataDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kenichiro HashizumeGSI Co., Ltd., Tokyo, Japan.
Kazuho UshiwataGSI Co., Ltd., Tokyo, Japan.
Hirotaro IwaseDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yohsuke MakinoDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Tetsuo UshikuDepartment of Pathology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Shinji AkitomiDepartment of Forensic Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Masaki ImaiDivision of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Hisako SaitohDepartment of Legal Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Yoshihiro KawaokaDivision of Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.ORCID 0000-0001-5061-8296
Chiba University · JPTokyo University of Science · JPJapan Medical Association · JPThe University of Tokyo · JPUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although it has been 2.5 years since the coronavirus disease 2019 (COVID-19) pandemic began, the transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a dead infected body remains unclear, and in Japan, bereaved family members are often not allowed to view in person a loved one who has died from COVID-19. In this study, we analyzed the possibility of SARS-CoV-2 transmission from a dead body using a hamster model. We also analyzed the effect of "angel care"--in which the pharynx, nostrils, and rectum are plugged--and embalming on reducing transmissibility from dead bodies. We found that SARS-CoV-2 could be transmitted from the bodies of animals that had died within a few days of infection; however, angel care and embalming were effective in preventing transmission from the dead bodies. These results suggest that protection from infection is essential when in contact with a SARS-CoV-2-infected dead body and that sealing the cavities of a dead body is an important infection control step if embalming is not performed.

Indexed as

COVID-19SARS-CoV-2AnimalsCricetinaeInfection ControlJapananimal modelCOVID-19dead bodyembalmingSARS-CoV-2transmission

Identifiers

PMID36625587
PMCPMC9942556
OpenAlexW4313950051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.